ResMed, Verily Connect To Form Sleep Apnea JV

12 Jul 2018

Sleep disorder therapy specialist ResMed and Alphabet's health unit Verily are combining their expertise to form a new joint venture focused on developing solutions that will enable health care providers to better diagnose and manage sleep apnea and other breathing-related sleep problems.

Having already teamed up with other market leaders in the areas of surgery and diabetes, Alphabet's health unit Verily Life Sciences LLC is now targeting the sleep disorder space and teaming up with leading sleep company ResMed Inc. to form a joint venture focused on sleep apnea treatments and connected health products. In particular, the JV aims to develop software solutions that enable health care providers to better diagnose, treat and manage sleep apnea and other breathing-related sleep disorders.

Financial details of the agreement were not revealed. However, sleep apnea is a potentially serious disorder that affects an estimated...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Panel: FDA’s Home Healthcare Initiative Holds Promise, But Challenges Remain

06 Jun 2025

• By Elizabeth Orr

During a recent FDLI panel, experts discussed the FDA's Home Healthcare initiative, highlighting its potential benefits and challenges. Key issues include usability testing, reimbursement, labeling for home use, and the need for innovation while ensuring patient safety.